Nomad Power Solutions, Inc. (NMAD)
3.46
-0.03
(-0.86%)
USD |
NASDAQ |
Nov 06, 10:21
Nomad Power Solutions Net Income (Quarterly) : -2.344M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.344M |
| March 31, 2026 | -1.988M |
| December 31, 2025 | -2.544M |
| September 30, 2025 | -1.980M |
| June 30, 2025 | -0.7757M |
| March 31, 2025 | -0.7096M |
| December 31, 2024 | -0.6177M |
| September 30, 2024 | -0.986M |
| June 30, 2024 | -1.011M |
| March 31, 2024 | -0.9713M |
| December 31, 2023 | -1.032M |
| September 30, 2023 | -1.019M |
| June 30, 2023 | -1.668M |
| March 31, 2023 | -1.368M |
| December 31, 2022 | -1.631M |
| September 30, 2022 | -1.478M |
| June 30, 2022 | -1.546M |
| March 31, 2022 | -1.657M |
| December 31, 2021 | -2.029M |
| September 30, 2021 | -1.239M |
| June 30, 2021 | -1.733M |
| March 31, 2021 | -1.727M |
| December 31, 2020 | -0.9069M |
| September 30, 2020 | -1.602M |
| June 30, 2020 | -0.3731M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.3832M |
| December 31, 2019 | -0.3221M |
| September 30, 2019 | -1.079M |
| June 30, 2019 | -0.6105M |
| March 31, 2019 | -0.4287M |
| December 31, 2018 | -0.3486M |
| September 30, 2018 | -1.034M |
| June 30, 2018 | -0.3714M |
| March 31, 2018 | -0.3792M |
| December 31, 2017 | -0.4326M |
| September 30, 2017 | -0.4624M |
| June 30, 2017 | -0.2928M |
| March 31, 2017 | -0.6206M |
| December 31, 2016 | -0.5163M |
| September 30, 2016 | -0.6469M |
| June 30, 2016 | -0.555M |
| March 31, 2016 | -0.4165M |
| December 31, 2015 | -0.6139M |
| September 30, 2015 | -0.7797M |
| June 30, 2015 | -0.5007M |
| March 31, 2015 | -0.9579M |
| December 31, 2014 | -0.5947M |
| September 30, 2014 | -0.5014M |
| June 30, 2014 | -0.7413M |
| March 31, 2014 | -0.9288M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 53.52M |
| Alnylam Pharmaceuticals, Inc. | 2.167B |
| Anika Therapeutics, Inc. | 3.309M |
| Savara, Inc. | -40.23M |
| Vericel Corp. | 2.206M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 2.187M |
| EPS Diluted (Quarterly) | -0.1623 |
| Enterprise Value | 43.31M |
| Earnings Yield | -28.92% |
| Normalized Earnings Yield | -28.31 |